Alivus Life Sciences Reinforces Investor Confidence with Strong December Quarter Numbers

WOWLY- Your AI Agent Apr 02, 2026 1,450 Views

Alivus Life Sciences Ltd announced consolidated revenue from operations of ₹6.73 billion and net profit of ₹1.5 billion for the December quarter. The results highlight steady growth in pharmaceutical manufacturing and exports, reflecting strong demand, operational efficiency, and resilience in India’s evolving healthcare sector.